Zebra Announces Regulatory Approval of its Deep Learning Imaging Analytics Engine

Zebra Medical VisionZebra Medical Vision, the leading machine learning imaging analytics company, announces that the company has been granted the CE approval and subsequent release of its Deep Learning Analytics Engine in Europe, as well as regulatory clearance and product release in Australia and New Zealand. The company's Analytics Engine provides automated analysis of imaging data, helping radiologists provide faster, more accurate and comprehensive reports. The Engine can be integrated into PACS, RIS, Reporting and EMR systems, providing a seamless flow for physicians.

AI in healthcare has been gaining significant support and adoption over the past 12 months. In a recent Research and Markets report, it was estimated that Artificial Intelligence in healthcare will witness a CAGR of 62.2% between 2016-2022. The Zebra-Med Engine currently analyzes CT data for signs of:

  • Fatty Liver
  • Excess coronary calcium
  • Emphysema
  • Low bone density
  • Vertebral compression fractures

In addition, more than a dozen new algorithms that detect life threatening diseases will be released in the coming months. Zebra-Med's engine can be deployed in both cloud and on-premise configurations, and its insights help radiologists provide more comprehensive, consistent reports. The company's unique platform allows healthcare organizations to discover chronic diseases earlier, giving those organizations the opportunity to establish preventative care programs, improving care while reducing the overall patient treatment costs.

"Machine Learning will change the way Radiology is practiced in the coming years," says Prof. Gabriel Krestin, Chairman of the Department of Radiology and Nuclear Medicine at Erasmus MC, University Medical Centre Rotterdam, the Netherlands. "I believe it will make radiologists more productive, and I also believe that new use cases and value propositions will emerge as the technology is implemented widely. It is a very exciting time for radiology."

"These recent regulatory approvals allow us to continue driving adoption of our Analytics Engine globally, where we see significant interest in countries that have a problematic ratio of radiologists per capita. Providing tools that assist them in delivering better care is critical and is the driving force behind our mission," says Elad Benjamin, Co-Founder and CEO at Zebra-Med. "We have already begun working with luminary university hospitals in Europe, and will continue to expand our footprint across the region."

About Zebra Medical Vision
A FastCompany Top 5 Machine Learning startup, Zebra Medical Vision uses machine and deep learning to create and provide next generation products and services to the healthcare industry. Its Imaging Analytics Platform allows healthcare institutions to identify patients at risk of disease, and offer improved, preventative treatment pathways to better patient care. Headquartered in Kibbutz Shefayim, Israel, the company was founded in 2014 by co-founders Eyal Toledano, Eyal Gura, and Elad Benjamin, and funded by Khosla Ventures, Marc Benioff, Intermountain Investment Fund, OurCrowd and Dolby Ventures. For more information visit www.zebra-med.com.

Most Popular Now

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...

Virtual Reality Environment for Teens ma…

Social media. The climate crisis. Political polarization. The tumult of a pandemic and online learning. Teens today are dealing with unprecedented stressors, and over the past decade their mental health...

AI Predicts Tumor-Killing Cells with Hig…

Using artificial intelligence, Ludwig Cancer Research scientists have developed a powerful predictive model for identifying the most potent cancer killing immune cells for use in cancer immunotherapies. Combined with additional algorithms...

Researchers Use Foundation Models to Dis…

Researchers at Mass General Brigham have harnessed the technology behind foundation models, which power tools like ChatGPT, to discover new cancer imaging biomarkers that could transform how patterns are identified...